Household Healthcare Sector

ProtoKinetix

Market Cap: US$3.3m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Bionoid Pharma

Market Cap: US$3.3m

Engages in the hemp cultivation business.

Biodexa Pharmaceuticals

Market Cap: US$3.3m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

RedHill Biopharma

Market Cap: US$3.3m

A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

Lobe Sciences

Market Cap: CA$4.6m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

4Front Ventures

Market Cap: CA$4.6m

Owns and manages licensed cannabis facilities in state-licensed markets in the United States.

City View Green Holdings

Market Cap: CA$4.6m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Protagenic Therapeutics

Market Cap: US$3.3m

A biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

InMed Pharmaceuticals

Market Cap: US$3.3m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

NovaBay Pharmaceuticals

Market Cap: US$3.3m

Does not have significant operations.

iCoreConnect

Market Cap: US$3.2m

A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.

Silo Pharma

Market Cap: US$3.2m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

Synaptogenix

Market Cap: US$3.2m

Operates as a biopharmaceutical company.

SciSparc

Market Cap: US$3.2m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

Ensysce Biosciences

Market Cap: US$3.1m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Artelo Biosciences

Market Cap: US$3.1m

A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

Galmed Pharmaceuticals

Market Cap: US$3.1m

A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.

Ethema Health

Market Cap: US$3.1m

Operates behavioral healthcare space specifically in the treatment of substance use disorders.

Actavia Life Sciences

Market Cap: US$3.1m

A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.

Longevity Health Holdings

Market Cap: US$3.1m

A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.

Kineta

Market Cap: US$3.1m

A clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States.

Uscom

Market Cap: AU$4.8m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

Enveric Biosciences

Market Cap: US$3.1m

A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

Oxford Cannabinoid Technologies Holdings

Market Cap: US$3.0m

A pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines.

ASEP Medical Holdings

Market Cap: CA$4.2m

Focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.

Global Health

Market Cap: AU$4.7m

Provides digital health solutions for the healthcare industry in Australia.

QHSLab

Market Cap: US$3.0m

A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.

Bone Biologics

Market Cap: US$3.0m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

VirExit Technologies

Market Cap: US$2.9m

Develops and provides antiviral technologies, personal protective equipment, and health and wellness products.

Jaguar Health

Market Cap: US$2.9m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

iSpecimen

Market Cap: US$2.9m

Operates marketplace that provides biospecimens to life science researchers worldwide.

CERo Therapeutics Holdings

Market Cap: US$2.9m

An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.

Akanda

Market Cap: US$2.8m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.

BioTech Medics

Market Cap: US$2.8m

Operates as a medical-based holding company.

TILT Holdings

Market Cap: CA$3.9m

Provides various cannabis products and services in the United States, Canada, and internationally.

9 Meters Biopharma

Market Cap: US$2.8m

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.